Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007
作者： S. Tendolkar , J. Kroeger , D. J. Diekema , M. A. Pfaller , S. A. Messer
DOI: 10.1128/JCM.00946-09
关键词:
摘要: We examined the susceptibilities to fluconazole of 642 bloodstream infection (BSI) isolates Candida glabrata and grouped by patient age geographic location within United States. Susceptibility C. was lowest in northeast region (46%) highest west (76%). The frequencies isolation resistance among BSI were higher present study (years 2001 2007) than a previous conducted from 1992 2001. Whereas frequency increased with age, rate declined. oldest group (≥80 years) had proportion that (32%) (5%).
cabdirect.org
sci-hub.se 参考文章(94)
P Marichal, H Vanden Bossche, F C Odds, G Nobels, D W Warnock, V Timmerman, C Van Broeckhoven, S Fay, P Mose-Larsen, Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrobial Agents and Chemotherapy. ,vol. 41, pp. 2229- 2237 ,(1997) , 10.1128/AAC.41.10.2229
Boualem Sendid, Angélique Cotteau, Nadine François, Annie D'Haveloose, Annie Standaert, Daniel Camus, Daniel Poulain, Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links BMC Infectious Diseases. ,vol. 6, pp. 80- 80 ,(2006) , 10.1186/1471-2334-6-80
Michael A Pfaller, DJ Diekema, International Fungal Surveillance Participant Group, None, Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida Clinical Microbiology and Infection. ,vol. 10, pp. 11- 23 ,(2004) , 10.1111/J.1470-9465.2004.T01-1-00844.X
M.C. Arendrup, K. Fuursted, B. Gahrn-Hansen, H.C. Schønheyder, J.D. Knudsen, I.M. Jensen, B. Bruun, J.J. Christensen, H.K. Johansen, Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clinical Microbiology and Infection. ,vol. 14, pp. 487- 494 ,(2008) , 10.1111/J.1469-0691.2008.01954.X
S-Y Ruan, L-N Lee, J-S Jerng, C-J Yu, P-R Hsueh, None, Candida glabrata fungaemia in intensive care units Clinical Microbiology and Infection. ,vol. 14, pp. 136- 140 ,(2008) , 10.1111/J.1469-0691.2007.01892.X
L. Li, S. Redding, A. Dongari-Bagtzoglou, Candida glabrata, an Emerging Oral Opportunistic Pathogen Journal of Dental Research. ,vol. 86, pp. 204- 215 ,(2007) , 10.1177/154405910708600304
Kevin W. Garey, Manjunath P. Pai, Katie J. Suda, Robin S. Turpin, Milind D. Rege, Dana E. Mingo, David T. Bearden, Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiology and Drug Safety. ,vol. 16, pp. 919- 927 ,(2007) , 10.1002/PDS.1365
I. Xess, N. Jain, F. Hasan, P. Mandal, U. Banerjee, Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection. ,vol. 35, pp. 256- 259 ,(2007) , 10.1007/S15010-007-6144-6
Ray Hachem, Hend Hanna, Dimitrios Kontoyiannis, Ying Jiang, Issam Raad, The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy Cancer. ,vol. 112, pp. 2493- 2499 ,(2008) , 10.1002/CNCR.23466
MARIÉ DRIESSEN, JEFF B. ELLIS, PETER A. COOPER, STEPHEN WAINER, FAITH MUWAZI, DEIDRE HAHN, HERMIEN GOUS, FRANÇOIS P. R. DE VILLIERS, Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatric Infectious Disease Journal. ,vol. 15, pp. 1107- 1112 ,(1996) , 10.1097/00006454-199612000-00011